Rhon-klinikum Ag · XETR:RHK
Rhon-klinikum — 9M 2017 Earnings Presentation
10 slides from Rhon-klinikum's earnings presentation, Nov 10, 2017
Slide 1: Results for the First Nine Months of 2017
Results for the First Nine Months of 2017 10 November 2017 Stephan Holzinger, CEO Kai Knitter RHÖN-KLINIKUM AG - First Quarter 2017 Results - as of May 5, 2017 1
Slide 2: Disclaimer
Disclaimer This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for use during this presentation. It must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose
Slide 3: Highlights of Third Quarter 2017
Highlights of Third Quarter 2017 Accretion in volumes affected by regulatory framework, shifting demand and strike days at UKGM +2.6% increase in inpatient and outpatient cases to 631,653 cases with -1.0% DRG case mix points in first nine months Campus Bad Neustadt Good progress on all const
Slide 4: Key P&L Figures First Nine Months of 2017
Key P&L Figures First Nine Months of 2017 Performance* vs. 9M performance constrained by regulatory headwinds 9M 2017 in € millions 9M 2016 and a weakening on the volume side Revenue 902.5 100.0% 1.9% Discounts in reimbursement scheme, MDK corrections and lower volumes are burdening sales growth P
Slide 5: Core Balance Sheet Figures as of 30 September 2017
Core Balance Sheet Figures as of 30 September 2017 €1,456m €1,456m 63 % €917m Non-current assets €1,116m 77 % Equity €5m cash €539m 37 % Current assets € 27m Non-current liabilities 2% €314m Current liabilities 22 % €257m cash Assets Equity & Liabilities Strong cash position (€262m) and sustainabl
Slide 6: Financial Outlook & Main Regulatory Changes
Financial Outlook & Main Regulatory Changes First impetus from 2018 pricing General wage sum increase (initial DRG inflator) 2.8% 2.95% 2.97% +2.97% initial DRG inflator for 2018 with expected 3.0% 3,0% 2.5% 2.5% 2.0% 2.0% growth rate of +2.5% for the RHÖN-portfolio 2.0% 2,0% 1.4% 1.5% Negotiati
Slide 7: Financial Calendar
Appendix Financial Calendar FY 2018 23 February 2018 Preliminary results for financial year 2017 29 March 2018 Press conference: publication of annual financial report 2017 4 May 2018 Publication of interim report for the quarter ending 31 March 2018 6 June 2018 Annual General Meeting 2 Au
Slide 8: Price Regulation at a Glance
Appendix Price Regulation at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) DRG inflation in 2017: +2.5% (2016: +2.
Slide 9: Shareholder Base
Appendix Shareholder Base Shareholder Structure as of 30 September 2017, according to the most recent notifications of voting rights at that time 25.1% Asklepios 29.8% 1) 33.0% Free Float 67.0% Strategic 3.2% Investors Landeskrankenhilfe 25.0% 3) 5.4% B. Braun Ingeborg Münch 11.5% 2) Eugen Münch/HCM
Slide 10: IR Contact Data
Appendix IR Contact Data Contact Kai Knitter, Head of Corporate Communication and Investor Relations Tel: +49 9771 65 1328, email: ir@rhoen-klinikum-ag.com RHÖN-KLINIKUM AG - Results for the First Nine Months of 2017 - 10 November 2017 10